Biotech M&A, Earnings to Rise, Werber Says

Biotech M&A, Earnings to Rise, Werber Says Play

Nov. 5 (Bloomberg) -- Yaron Werber, biotechnology analyst at Citigroup Inc., talks with Bloomberg Industries senior healthcare analyst Andrew Berens and Bloomberg's Sasha Damouni about the biotechnology industry and the outlook for earnings and mergers and acquisitions. (This is an excerpt. Source: Bloomberg)

  • On Air Now

    Charlie Rose Watch Now

  • Next

    Bloomberg West

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus